Inclusion completed

Safety, pharmacokinetics and efficacy of AXP107-11 in patients with standard gemcitabine (Gemzar®) treatment in patients with locally advanced or metastatic, unresectable, adenocarcinoma of the pancreas, stage III-IV.

Cancer type: Pancreatic cancer

Phase: I/II

Principal Investigator: Frödin Jan-Erik

Country: SE

Keywords: Sweden, AXP107-11, pancreatic cancer

Status: Inclusion completed

Link to